Estradiol increases guanosine 5′-triphosphate cyclohydrolase expression via the nitric oxide-mediated activation of cyclic adenosine 5′-monophosphate response element binding protein

Xutong Sun, Sanjiv Kumar, Jing Tian, Stephen Matthew Black

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

A number of studies have demonstrated that estradiol can stimulate endothelial nitric oxide synthase expression and activity, resulting in enhanced nitric oxide (NO) generation. However, its effect on the NO synthase cofactor, tetrahydrobiopterin are less clear. Cellular tetrahydrobiopterin levels are regulated, at least in part, by GTP cyclohydrolase 1 (GCH1). Thus, the purpose of this study was to determine the effect of estradiol on GCH1 expression and the regulatory mechanisms in pulmonary arterial endothelial cells. Our data indicate that 17β-estradiol (E2) increases GCH1 transcription in a dose- and time-dependent manner, whereas estrogen receptor antagonism or NOsynthase inhibition attenuated E2-stimulated GCH1 expression. Analysis of the GCH1 promoter fragment responsive to E2 revealed the presence of a cAMP response element, and we found that E2 triggers a rapid but transient elevation of phospho-cAMP response element-binding protein (CREB; <1 h) followed by a second sustained rise after 6 h. EMSA analysis revealed an increase in the binding of CREB during E2 treatment and mutation of the cAMP response element in the GCH1 promoter attenuated the E2-mediated increase in transcription. Furthermore, inhibition of the cAMP-dependent kinase, protein kinase A (PKA) completely abolished the E2-stimulated GCH1 promoter activity, whereas the stimulation of cAMP levels with forskolin increased GCH1 promoter activity, indicating the key role of cAMP in regulating GCH1 promoter activity. In conclusion, our results demonstrate that estradiol can modulate GCH1 expression via NO-mediated activation of CREB in pulmonary arterial endothelial cells. These findings provide new insight into the vascular protective effect of estradiol.

Original languageEnglish (US)
Pages (from-to)3742-3752
Number of pages11
JournalEndocrinology
Volume150
Issue number8
DOIs
StatePublished - Aug 1 2009

Fingerprint

GTP Cyclohydrolase
Response Elements
Guanosine Triphosphate
Cyclic AMP
Estradiol
Carrier Proteins
Nitric Oxide
Endothelial Cells
Cyclic AMP Response Element-Binding Protein
Lung
Nitric Oxide Synthase Type III
Colforsin
Cyclic AMP-Dependent Protein Kinases
Nitric Oxide Synthase
Estrogen Receptors
Blood Vessels
Phosphotransferases

ASJC Scopus subject areas

  • Endocrinology

Cite this

Estradiol increases guanosine 5′-triphosphate cyclohydrolase expression via the nitric oxide-mediated activation of cyclic adenosine 5′-monophosphate response element binding protein. / Sun, Xutong; Kumar, Sanjiv; Tian, Jing; Black, Stephen Matthew.

In: Endocrinology, Vol. 150, No. 8, 01.08.2009, p. 3742-3752.

Research output: Contribution to journalArticle

@article{2cf073c1002a4f2f9bd59670b556f735,
title = "Estradiol increases guanosine 5′-triphosphate cyclohydrolase expression via the nitric oxide-mediated activation of cyclic adenosine 5′-monophosphate response element binding protein",
abstract = "A number of studies have demonstrated that estradiol can stimulate endothelial nitric oxide synthase expression and activity, resulting in enhanced nitric oxide (NO) generation. However, its effect on the NO synthase cofactor, tetrahydrobiopterin are less clear. Cellular tetrahydrobiopterin levels are regulated, at least in part, by GTP cyclohydrolase 1 (GCH1). Thus, the purpose of this study was to determine the effect of estradiol on GCH1 expression and the regulatory mechanisms in pulmonary arterial endothelial cells. Our data indicate that 17β-estradiol (E2) increases GCH1 transcription in a dose- and time-dependent manner, whereas estrogen receptor antagonism or NOsynthase inhibition attenuated E2-stimulated GCH1 expression. Analysis of the GCH1 promoter fragment responsive to E2 revealed the presence of a cAMP response element, and we found that E2 triggers a rapid but transient elevation of phospho-cAMP response element-binding protein (CREB; <1 h) followed by a second sustained rise after 6 h. EMSA analysis revealed an increase in the binding of CREB during E2 treatment and mutation of the cAMP response element in the GCH1 promoter attenuated the E2-mediated increase in transcription. Furthermore, inhibition of the cAMP-dependent kinase, protein kinase A (PKA) completely abolished the E2-stimulated GCH1 promoter activity, whereas the stimulation of cAMP levels with forskolin increased GCH1 promoter activity, indicating the key role of cAMP in regulating GCH1 promoter activity. In conclusion, our results demonstrate that estradiol can modulate GCH1 expression via NO-mediated activation of CREB in pulmonary arterial endothelial cells. These findings provide new insight into the vascular protective effect of estradiol.",
author = "Xutong Sun and Sanjiv Kumar and Jing Tian and Black, {Stephen Matthew}",
year = "2009",
month = "8",
day = "1",
doi = "10.1210/en.2008-1464",
language = "English (US)",
volume = "150",
pages = "3742--3752",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "8",

}

TY - JOUR

T1 - Estradiol increases guanosine 5′-triphosphate cyclohydrolase expression via the nitric oxide-mediated activation of cyclic adenosine 5′-monophosphate response element binding protein

AU - Sun, Xutong

AU - Kumar, Sanjiv

AU - Tian, Jing

AU - Black, Stephen Matthew

PY - 2009/8/1

Y1 - 2009/8/1

N2 - A number of studies have demonstrated that estradiol can stimulate endothelial nitric oxide synthase expression and activity, resulting in enhanced nitric oxide (NO) generation. However, its effect on the NO synthase cofactor, tetrahydrobiopterin are less clear. Cellular tetrahydrobiopterin levels are regulated, at least in part, by GTP cyclohydrolase 1 (GCH1). Thus, the purpose of this study was to determine the effect of estradiol on GCH1 expression and the regulatory mechanisms in pulmonary arterial endothelial cells. Our data indicate that 17β-estradiol (E2) increases GCH1 transcription in a dose- and time-dependent manner, whereas estrogen receptor antagonism or NOsynthase inhibition attenuated E2-stimulated GCH1 expression. Analysis of the GCH1 promoter fragment responsive to E2 revealed the presence of a cAMP response element, and we found that E2 triggers a rapid but transient elevation of phospho-cAMP response element-binding protein (CREB; <1 h) followed by a second sustained rise after 6 h. EMSA analysis revealed an increase in the binding of CREB during E2 treatment and mutation of the cAMP response element in the GCH1 promoter attenuated the E2-mediated increase in transcription. Furthermore, inhibition of the cAMP-dependent kinase, protein kinase A (PKA) completely abolished the E2-stimulated GCH1 promoter activity, whereas the stimulation of cAMP levels with forskolin increased GCH1 promoter activity, indicating the key role of cAMP in regulating GCH1 promoter activity. In conclusion, our results demonstrate that estradiol can modulate GCH1 expression via NO-mediated activation of CREB in pulmonary arterial endothelial cells. These findings provide new insight into the vascular protective effect of estradiol.

AB - A number of studies have demonstrated that estradiol can stimulate endothelial nitric oxide synthase expression and activity, resulting in enhanced nitric oxide (NO) generation. However, its effect on the NO synthase cofactor, tetrahydrobiopterin are less clear. Cellular tetrahydrobiopterin levels are regulated, at least in part, by GTP cyclohydrolase 1 (GCH1). Thus, the purpose of this study was to determine the effect of estradiol on GCH1 expression and the regulatory mechanisms in pulmonary arterial endothelial cells. Our data indicate that 17β-estradiol (E2) increases GCH1 transcription in a dose- and time-dependent manner, whereas estrogen receptor antagonism or NOsynthase inhibition attenuated E2-stimulated GCH1 expression. Analysis of the GCH1 promoter fragment responsive to E2 revealed the presence of a cAMP response element, and we found that E2 triggers a rapid but transient elevation of phospho-cAMP response element-binding protein (CREB; <1 h) followed by a second sustained rise after 6 h. EMSA analysis revealed an increase in the binding of CREB during E2 treatment and mutation of the cAMP response element in the GCH1 promoter attenuated the E2-mediated increase in transcription. Furthermore, inhibition of the cAMP-dependent kinase, protein kinase A (PKA) completely abolished the E2-stimulated GCH1 promoter activity, whereas the stimulation of cAMP levels with forskolin increased GCH1 promoter activity, indicating the key role of cAMP in regulating GCH1 promoter activity. In conclusion, our results demonstrate that estradiol can modulate GCH1 expression via NO-mediated activation of CREB in pulmonary arterial endothelial cells. These findings provide new insight into the vascular protective effect of estradiol.

UR - http://www.scopus.com/inward/record.url?scp=67651151317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651151317&partnerID=8YFLogxK

U2 - 10.1210/en.2008-1464

DO - 10.1210/en.2008-1464

M3 - Article

C2 - 19389836

AN - SCOPUS:67651151317

VL - 150

SP - 3742

EP - 3752

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 8

ER -